Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-21-009931)

Filing Details

Accession Number:
0001209191-21-009931
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-11 20:28:35
Reporting Period:
2021-02-09
Accepted Time:
2021-02-11 20:28:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595893 Turning Point Therapeutics Inc. TPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571469 Athena Countouriotis C/O Turning Point Therapeutics, Inc.
10628 Science Center Drive, Ste. 200
San Diego CA 92121		 President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-09 18,000 $3.20 68,195 No 4 M Direct
Common Stock Acquisiton 2021-02-09 7,666 $3.20 75,861 No 4 M Direct
Common Stock Disposition 2021-02-09 6,200 $136.29 69,661 No 4 S Direct
Common Stock Disposition 2021-02-09 103 $137.58 69,558 No 4 S Direct
Common Stock Disposition 2021-02-09 4,969 $138.66 64,589 No 4 S Direct
Common Stock Disposition 2021-02-09 13,290 $139.69 51,299 No 4 S Direct
Common Stock Disposition 2021-02-09 1,104 $140.24 50,195 No 4 S Direct
Common Stock Acquisiton 2021-02-10 25,392 $3.20 75,587 No 4 M Direct
Common Stock Disposition 2021-02-10 1,025 $134.34 74,562 No 4 S Direct
Common Stock Disposition 2021-02-10 5,227 $135.72 69,335 No 4 S Direct
Common Stock Disposition 2021-02-10 16,626 $136.42 52,709 No 4 S Direct
Common Stock Disposition 2021-02-10 2,081 $137.46 50,628 No 4 S Direct
Common Stock Disposition 2021-02-10 433 $138.19 50,195 No 4 S Direct
Common Stock Acquisiton 2021-02-11 8,942 $3.20 59,137 No 4 M Direct
Common Stock Disposition 2021-02-11 4,319 $136.45 54,818 No 4 S Direct
Common Stock Disposition 2021-02-11 1,571 $137.66 53,247 No 4 S Direct
Common Stock Disposition 2021-02-11 3,052 $138.55 50,195 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-02-09 18,000 $0.00 18,000 $3.20
Common Stock Stock Option (right to buy) Disposition 2021-02-09 7,666 $0.00 7,666 $3.20
Common Stock Stock Option (right to buy) Disposition 2021-02-10 25,392 $0.00 25,392 $3.20
Common Stock Stock Option (right to buy) Disposition 2021-02-11 8,942 $0.00 8,942 $3.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
207,723 2028-06-05 No 4 M Direct
67,575 2028-06-05 No 4 M Direct
182,331 2028-06-05 No 4 M Direct
173,389 2028-06-05 No 4 M Direct
Footnotes
  1. Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
  2. The weighted average sale price for the transaction reported was $136.29, and the range of prices were between $136.00 and $137. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. The weighted average sale price for the transaction reported was $137.58, and the range of prices were between $137.035 and $138. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. The weighted average sale price for the transaction reported was $138.66, and the range of prices were between $138.09 and $139.085. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. The weighted average sale price for the transaction reported was $139.69, and the range of prices were between $139.235 and $140.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  6. The weighted average sale price for the transaction reported was $140.24, and the range of prices were between $140.24 and $140.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  7. The weighted average sale price for the transaction reported was $134.34, and the range of prices were between $134.00 and $135.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  8. The weighted average sale price for the transaction reported was $135.72, and the range of prices were between $135.015 and $136.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  9. The weighted average sale price for the transaction reported was $136.42, and the range of prices were between $136.02 and $137.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  10. The weighted average sale price for the transaction reported was $137.46, and the range of prices were between $137.04 and $138.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  11. The weighted average sale price for the transaction reported was $138.19, and the range of prices were between $138.05 and $138.425. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  12. The weighted average sale price for the transaction reported was $136.45, and the range of prices were between $136.00 and $137.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  13. The weighted average sale price for the transaction reported was $137.66, and the range of prices were between $137.025 and $138.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  14. The weighted average sale price for the transaction reported was $138.55, and the range of prices were between $138.09 and $139.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  15. 25% of the shares vested on May 7, 2019 and 1/48th of the shares vest monthly thereafter over the next three years.
  16. 25% of the shares vested on June 29, 2019 and 1/48th of the shares vest monthly thereafter over the next three years.
Insider Monkey Quarterly Strategy
+246.9% Insider Monkey Quarterly Strategy
+107.5% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through Feb 16th, 2024)